JAMA Dermatology,
This case report suggests that the combination of pertuzumab-based targeted therapy with taxane chemotherapy may develop into a…
Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report
Overview of attention for article published in JAMA Dermatology, January 2016
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (73rd percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 6 Mendeley